METODO DI BELLA > INDICE DELLA DOCUMENTAZIONE > Area Pazienti - Documentazione

 
 
Area Pazienti - Documentazione
 
 
A randomized phase II trial of mitoxantrone, estramustine and vinorelbine or bcl-2 modulation with 13-cis retinoic acid, interferon and paclitaxel in patients with metastatic castrate-resistant prostate cancer: ECOG3899. (12/04/2011)
Dettaglio
Retinoic acid regulates Fas-induced apoptosis in Jurkat T cells: reversal of mitogen-mediated repression of Fas DISC assembly. (12/04/2011)
Dettaglio
Treatment of advanced hepatocellular carcinoma with long-acting octreotide: a phase III multicentre, randomised, double blind placebo-controlled study. (12/04/2011)
Dettaglio
Transcriptional activation of the mixed lineage leukemia-p27Kip1 pathway by a somatostatin analogue. (12/04/2011)
Dettaglio
Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence. (12/04/2011)
Dettaglio
Laryngeal paragangliomas - controversies in diagnosis and management. (12/04/2011)
Dettaglio
Somatostatin receptor expression in thymic tumors. (12/04/2011)
Dettaglio
Plasma carotenoids, retinol and tocopherol levels and the risk of ovarian cancer. (12/04/2011)
Dettaglio
Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome. (12/04/2011)
Dettaglio
Vitamin A metabolism is impaired in human ovarian cancer (12/04/2011)
Dettaglio
Regulation of growth factors in hormone- and drug-resistant prostate cancer cells by synergistic combination of docetaxel and octreotide. (12/04/2011)
Dettaglio
Highlights of regional meeting of Italian Southern Oncological Group (GOIM): focus on hepatocellular carcinoma: biological and clinical background, therapeutic guide-lines and perspectives. (12/04/2011)
Dettaglio
Retinoid-induced histone deacetylation inhibits telomerase activity in estrogen receptor-negative breast cancer cells. (12/04/2011)
Dettaglio
Retinoids, retinoic acid receptors, and cancer. (12/04/2011)
Dettaglio
A novel therapeutic combination for neuroblastoma: the vascular endothelial growth factor receptor/epidermal growth factor receptor/rearranged during transfection inhibitor vandetanib with 13-cis-retinoic acid. (12/04/2011)
Dettaglio
 
 
 
Scorri con le frecce per visualizzare le pagine della ricerca 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 |
 
 

Stampa